In addition, a study conducted by Wei et al. demonstrated that circCDYL promoted the malignant transformation of hepatoma by controlling the tumor-initiating properties of hepatocellular carcinoma cells via activating the PI3K-AKT-mTORC1/β-catenin and NOTCH2 pathways [15]. Here, NOTCH2 is linked to hepatocellular carcinoma.